Great-West Lifeco Inc. (TSX:GWO)
Canada · Delayed Price · Currency is CAD | Market Cap | 80.47B +48.3% |
| Revenue (ttm) | 36.42B +3.8% |
| Net Income | 4.44B +20.0% |
| EPS | 4.84 +20.9% |
| Shares Out | 895.20M |
| PE Ratio | 18.56 |
| Forward PE | 14.99 |
| Dividend | 2.68 (2.98%) |
| Ex-Dividend Date | Sep 1, 2026 |
| Volume | 428,084 |
| Open | 91.32 |
| Previous Close | 91.83 |
| Day's Range | 89.24 - 91.74 |
| 52-Week Range | 58.50 - 95.96 |
| Beta | 0.66 |
| Analysts | Buy |
| Price Target | 94.92 (+5.6%) |
| Earnings Date | Nov 4, 2026 |
About Great-West Lifeco
Great-West Lifeco Inc. engages in the life and health insurance, retirement savings, wealth and asset management, and reinsurance businesses in Canada, the United States, and Europe. The company offers life, accidental death and dismemberment, critical illness, disability, health and dental protection, and creditor insurance products; and retirement savings, income and annuity products, and other specialty products to individuals, families, businesses, and organizations. It also provides individual product solutions and employer-sponsored retir... [Read more]
Financial Performance
In 2025, Great-West Lifeco's revenue was 35.45 billion, an increase of 2.04% compared to the previous year's 34.74 billion. Earnings were 3.96 billion, an increase of 0.51%.
Financial StatementsAnalyst Summary
According to 13 analysts, the average rating for GWO stock is "Buy." The 12-month stock price target is $94.92, which is an increase of 5.60% from the latest price.
News
Great-West Lifeco price target raised to C$91 from C$87 at Barclays
Barclays raised the firm’s price target on Great-West Lifeco (GWLIF) to C$91 from C$87 and keeps an Equal Weight rating on the shares. The firm adjusted targets in the life…
Great-West Lifeco initiated with an In Line at Evercore ISI
Evercore ISI initiated coverage of Great-West Lifeco (GWLIF) with an In Line rating and C$100 price target The firm views the company as well positioned to win in the U.S.
Great-West Lifeco Transcript: Scotiabank’s 27th Annual Financials Summit
ROE reached 19.3% in Q2, with capital-light earnings and AI expected to support further growth. Empower margins remain strong, while investment, acquisitions and buybacks support strategic expansion.
Great-West Lifeco Slides: Investor presentation
Great-West Lifeco has posted slides in relation to its latest quarterly earnings report, which was published on August 4, 2026.
Great-West Lifeco Q2 Earnings Call Highlights
Great-West Lifeco TSE: GWO reported 15% year-over-year growth in second-quarter base earnings per share, supported by double-digit growth at its Empower retirement business and Capital and Risk Soluti...
Great-West Lifeco price target raised to C$91 from C$77 at RBC Capital
RBC Capital analyst Darko Mihelic raised the firm’s price target on Great-West Lifeco (GWLIF) to C$91 from C$77 and keeps a Sector Perform rating on the shares. Published first on…
Great-West Lifeco price target raised to C$97 from C$95 at CIBC
CIBC analyst Paul Holden raised the firm’s price target on Great-West Lifeco (GWLIF) to C$97 from C$95 and keeps an Outperformer rating on the shares.
Great-West Lifeco price target raised to C$100 from C$95 at Scotiabank
Scotiabank raised the firm’s price target on Great-West Lifeco (GWLIF) to C$100 from C$95 and keeps an Outperform rating on the shares.
Great-West Lifeco price target raised to C$106 from C$98 at TD Securities
TD Securities raised the firm’s price target on Great-West Lifeco (GWLIF) to C$106 from C$98 and keeps a Buy rating on the shares.
Great-West Lifeco Earnings Call Transcript: Q2 2026
Double-digit base EPS and ROE growth were driven by strong performance in Empower, CRS, and European operations, with significant capital deployment and robust cash generation. Empower's acquisition of Milliman and balance sheet optimization in Europe further enhance growth prospects.
Great-West Lifeco Report: Q2 2026
Great-West Lifeco published a report on July 29, 2026 containing material business information for investors and shareholders.
Great-West Lifeco MD&A: Q2 2026
Great-West Lifeco filed a regulatory document on July 29, 2026 disclosing important business information.
Great-West Lifeco Earnings release: Q2 2026
Great-West Lifeco released its Q2 2026 earnings on July 29, 2026, summarizing the period's financial results.
Great-West Lifeco Slides: Q2 2026
Great-West Lifeco has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 29, 2026.
Great-West Lifeco price target raised to C$87 from C$86 at Barclays
Barclays raised the firm’s price target on Great-West Lifeco (GWLIF) to C$87 from C$86 and keeps an Equal Weight rating on the shares.
Great-West Lifeco price target raised to C$95 from C$83 at Scotiabank
Scotiabank raised the firm’s price target on Great-West Lifeco (GWLIF) to C$95 from C$83 and keeps an Outperform rating on the shares.
Great-West Lifeco price target raised to C$86 from C$73 at Barclays
Barclays raised the firm’s price target on Great-West Lifeco (GWLIF) to C$86 from C$73 and keeps an Equal Weight rating on the shares.
Great West announces offering of Series 24 Preferred Shares
WINNIPEG, Manitoba, June 15, 2026 (GLOBE NEWSWIRE) -- Great-West Lifeco Inc. (TSX: GWO) (“Great West” or the “Corporation”) announced today that it has entered into an agreement with a syndicate of un...
Great-West Lifeco price target raised to C$77 from C$64 at RBC Capital
RBC Capital raised the firm’s price target on Great-West Lifeco (GWLIF) to C$77 from C$64 and keeps a Sector Perform rating on the shares.
Great-West Lifeco price target raised to C$83 from C$78 at Scotiabank
Scotiabank raised the firm’s price target on Great-West Lifeco (GWLIF) to C$83 from C$78 and keeps an Outperform rating on the shares.
Great-West Lifeco price target raised to C$76 from C$70 at BMO Capital
BMO Capital raised the firm’s price target on Great-West Lifeco (GWLIF) to C$76 from C$70 and keeps a Market Perform rating on the shares.
Great-West Lifeco price target raised to C$81 from C$75 at CIBC
CIBC raised the firm’s price target on Great-West Lifeco (GWLIF) to C$81 from C$75 and keeps an Outperformer rating on the shares.
Great-West Lifeco Slides: Investor presentation
Great-West Lifeco has posted slides in relation to its latest quarterly earnings report, which was published on May 8, 2026.
Great-West Lifeco price target raised to C$80 from C$73 at TD Securities
TD Securities raised the firm’s price target on Great-West Lifeco (GWLIF) to C$80 from C$73 and keeps a Buy rating on the shares.
Great-West Lifeco Earnings Call Transcript: Q1 2026
Double-digit earnings and EPS growth were achieved across all segments, with base ROE surpassing 19% for the first time. Strong capital generation, disciplined deployment, and robust segment performance support a positive outlook for 2026.